Home › GAEL › Filing
🔔 Get instant alerts when GAEL files quarterly results on BSE Start free trial →

Outcome of Board Meeting

Filed: 24 Oct 2026, 15:11 IST Exchange: NSE Category: Financial Results — Audited Results
FY2026 results (audited): Standalone: Revenue 57.3bn +4% y-y (55.4bn) PAT 3.05bn +21% y-y (2.52bn) Consolidated: Revenue 57.3bn +4% y-y (55.4bn) PAT 3.25bn +21% y-y (2.69bn) Q2FY27 results (unaudited): Standalone: Revenue 14.5bn -2.4% y-y (14.9bn) EBITDA 1.77bn +21.6% y-y (1.46bn) EBITDA margin 12.2% (9.8%) +240 bps y-y PAT 1.32bn +246.6% y-y (0.38bn) Consolidated: Revenue 14.5bn -2.4% y-y (14.9bn) EBITDA 1.77bn +21.6% y-y (1.46bn) EBITDA margin 12.2% (9.8%) +240 bps y-y PAT 1.32bn +246.6% y-y (0.38bn) Dividend: 0.30/share for FY2026 Commentary: Profit before tax rose sharply driven by maize processing segment growth and improved product mix; focus on scaling fermentation capacity and value-added products continues.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 GAEL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add GAEL to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Gujarat Ambuja Exports Limited

Important. The summary above is generated automatically from Gujarat Ambuja Exports Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.